Methods and Protocols

      Analysis of water, nicotine, triacetin in THS aerosol

      PMI

      Published on
      Jun 7, 2018
      Topic
      Summary

      The aerosol samples are generated by mean of a 20-port linear smoking machine equipped with a carbon monoxide analyser. The vapour phase is collected in a bag and the carbon monoxide content analysed using a non-dispersive infra-red analyser. The mainstream aerosol is collected on a 44mm Cambridge filter pad (CFP).The content of CFPs are extracted using an In-Situ extractor with isopropanol containing Internal standards (ISTDs), n-heptadecane and ethanol. The extracts are analyzed by Gas Chromatography (GC) with a Flame Ionization Detector (FID) and a Thermal Conductivity Detector (TCD). GC-FID is used for the determination of nicotine and triacetin a capillary column DB WAXETER, 15 mm × 0.32 mm, ID × 1.0 μm film thickness. GC-TCD is used for the determination of water using a packed column HaySep Q 80/100 mesh, 8 feet, external diameter of 1/8” and internal diameter of 2.1 mm. Results are expressed as mg/item for the Tobacco Heating System (THS), referred to as Platform 1 (P1) in the method.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.